Notice Type
Departmental
Notice Title

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: Caspofungin Apotex
Active Ingredient: Caspofungin acetate 55.52mg equivalent to caspofungin 50mg
Dosage Form: Powder for infusion concentrate
New Zealand Sponsor: Apotex NZ Limited
Manufacturer: Mefar Ilac Sanayii A.S., Istanbul, Turkey
   
Product: Caspofungin Apotex
Active Ingredient: Caspofungin acetate 77.69mg equivalent to caspofungin 70mg
Dosage Form: Powder for infusion concentrate
New Zealand Sponsor: Apotex NZ Limited
Manufacturer: Mefar Ilac Sanayii A.S., Istanbul, Turkey
   
Product: Ziextenzo
Active Ingredient: Pegfilgrastim 10mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer: Sandoz GmbH, Langkampfen, Austria


Dated this 26th day of March 2020.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).